NCT04834388View on ClinicalTrials.gov

Studying Anakinra to Reduce Secondary Brain Damage After Spontaneous Haemorrhagic Stroke

PHASE2RecruitingINTERVENTIONAL

Enrollment

75

Participants

Timeline

Start Date

August 10, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions

Intracerebral Hemorrhage

Interventions

DRUG

Anakinra

Anakinra treatment is started within 8 hours of symptom onset

Trial Locations (1)

Unknown

RECRUITING

Radboudumc, Nijmegen

Sponsors

Collaborators (1)

Dutch Heart Foundation

All Listed Sponsors

collaborator

Dutch Heart Foundation

OTHER

lead

Radboud University Medical Center

OTHER